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Results: The intracellular MIC in infected alveolar macrophages 
was 3.0 pg/mL after 24 h, rising to 10 g/mL after 48 h. Moxifloxacin 
treatment at 1.0, 2.0 and 4 mg/kg for 7 days pi .  prevented deaths 
and reduced viable bacteria in the lung,  compared with untreated 
controls. No remission of infection was evident 1 week after cessa- 
tion of treatment. After a single 4 mg/kg dose, serum levels of 2-4 
pg/mL were achieved for up to 6 h. Levels of moxifloxacin increased 
over 6 h in the lungs. Histology confirmed that treatment prevented 
dissemination of L. pneumophila to spleens of infected animals. 
Conclusions: The data suggest that moxifloxacin could be of 
value in the treatment of legionnaires‘ disease. 
wl Effect of pravastatin on Chlamydia 
pneumoniae infection 
L. Erkkila, K. Laitinen, M. Leinonen, P. Saikku. National Public 
Health Institute, Helsinki and Oulu, Finlaad 
Objectives: Statins may have other effects besides lowering serum 
lipids, Our aim was to study the possible effect of pravastatin on the 
growth of Chlamydia pneumoniae (Cpn), commonly found in athero- 
sclerotic lesions, in cell cultures. 
Methods: Cpn strain Kajaani 7 was used to inoculate Vero cells 
grown in 24-well plates. 3600 IFUs were used in duplicate. 
Pravastatin was used in final concentrations of 5, 10 or 20 mg/L. 
Pravastatin treatment started 1 day before the Cpn infection. Samples 
were collected daily, and cells were fixed and stained for inclusion 
counts. 
Results: Pravastatin seemed to have a weak positive effect on the 
uptake of chlamydia by the cells. Mean numbers of inclusions per 
slide 48 h after infection were 834, 1412, 1572 and 1640 in the wells 
treated with 0, 5, 10 and 20 mg/L ofpravastatin, respectively. A more 
significant difference was seen 72 h after infection, when the mean 
numbers were 928, 56, 67 and 1484 inclusions per slide in wells 
treated with 0, 5, 10 and 20 nig/L, respectively. 
Conclusions: Pravastarin Feems to have both enhancing and 
depressing dose-dependent effects on the growth of Cpn in Vero 
cells. Pravastatin promoted the uptake of chlamydia by the cells, but 
it also helped the host cell to get rid of the chlamydia. Further stud- 
ies are needed to elucidate its effect on chronic Cpn infection (e.g. 
in animal models), which might be more important in the develop- 
ment of coronary heart disease. 
Im] Once-daily dosing optimizes effectiveness 
and decreases toxicity of daptomycin 
F.B. Oleson, Jr’, C.L. Berman’, J.B. Kirkpatrick’, K.S. Regan’, J-J. 
Lail, EI? Tally’. ‘Cubist Pharmaceuticals, Inc., Cambridge, MA, 
ZConsultant, Wayland, MA, ’ WIL Research Laboratories, Ashlund, 
OH, USA 
Daptomycin is a novel lipopeptide antibiotic with potent bacterici- 
dal activity against Gram-positive bacteria, including resistant strains. 
Leggett et al have shown previously in a mouse thigh infection model 
that effectiveness of daptomycin is optimized by once-daily dosing, 
since C,,,,, was found to be the key PK parameter associated with 
eradication of infection. Skeletal muscle has been identified as the 
target organ of dapromycin toxicity, To investigate the potential 
effects of dose fractionation on toxicity, two studies were conducted 
in dogs comparing the effects of repeated intravenous administration 
once daily (q24h) versus every 8 h (q8h). Muscle toxicity did not 
appear to be directly related to C,,,,,, since both serum CPK increases 
and the incidence of microscopic myopathy observed at 25 ing/kg 
q8h were greater than at 75 mg/kg q24h despite the lower C,,,,. A 
4-5-fold increase in CPK levels was observed at a constant dose of 
25 mg/kg administered at intervals of q8h versus q24h. whereas a 
negligible difference was apparent at a constant interval of 24 h at 
doses of 25 versus 75 mg/kg. Furthermore, 5 mg/kg administered 
q24h caused no change in CPK, whereas a dose regimen of q8h was 
associated with a 3-fold increase in CPK at a comparable C,,,. 
Siniilarly, toxicity was not related primarily to AUC24h, since the 
toxicity observed at 25 mg/kg q8h was greater than at 75 mg/kg 
q24h, at approximately the same AUC. The data suggest that dosing 
interval had a greater influence on toxicity than did dose itself. Once- 
daily administration is hypothesized to allow greater time between 
doses for repair of subclinical muscle damage associated with dapto- 
niycin. These results suggest that once-daily dosing can minimize 
daptoniycin muscle toxicity, while optimizing its antimicrobial efi- 
cacy. 
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lp958] DNA and RNA PCR in the diagnosis of vertical 
transmission of HIV-1 
C. Munoz, A. Gonzalez-Cuevas, C. Fortuny T. Jnncosa, A. Gen6, 
C. Latorre. Hospital SantJoan de Deou, Barcelona, Spain 
Objectives: To evaluate the use of P C R  in the determination of 
DNA provirus and quantification of viremia in the vertical transmis- 
sion of HIV-1. 
Patients: All children born of anti-HIV-1-positive mothers 
uanuary 1995 to December 1997) and checked in our hospital. 
Methods: HIV Ab (Cobas Core, Roche), P24 Ag (Innotest HIV, 
Innogenetics) and DNA provirus of HIV-1 (Amplicor HIV-1, 
Roche) were tested at 0 (according to availability), I, 3 , 6, 12 and 
18 months. In infected patients, viral RNA was quantified (HIV-1 
monitor, Roche) retrospectively in the first diagnostic sample. 
Results: 104 incants were studied. Median age at first determina- 
tion was 81 days (range: 0 days to 22 months). Vertical transmission 
rate was 7.6% (8 infected patients). Sensitivities of P C R  and P24 Ag 
in the first determination were 100% and 50% and specificities were 
100% and 95.4%. Only one of the eight infected patients had received 
correct zidovudine prophylaxis, and only two of the mothers knew 
they were infected before delivery. The median plasma HIV-1 RNA 
at diagnosis was 1 405 176 copieslml (6.1 loglo) in the eight infants, 
and it was always at least 100 000 copies. 
Conclusions: Determination of DNA provirus is an excellent 
method for diagnosis of vertical transmission of HIV-1, offering the 
possibility of early intervention. The high viral load during the first 
years of life possibly reflects the fact that the infant immune system 
is less effective than the adult’s for viral infection control. 
[m Differences in economiclclinical outcomes of 
HIV care by ethnicity: a Ryan White experience 
M.K. Rawling;’, M. Pasleyl, C. de Guzman’, D. Lapins2. 
‘Southeast Dallas Health Center, Parkland Health G. Hospital System, 
Dallas, Exas, ’Clinial Partners, San Francisco, CA, USA 
Objectives: To determine any disproportion in 0 1  incidence rate 
(OIIR), hospital admissions and cost by ethnicity among HIV- 
infected individuals seen in the Community Oriented Primary Care 
Program at Parkland Health & Hospital System (PHHS) in Dallas, 
TX. 
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Methods: Analysis of PHlHS claims data on 644 HIV-infected 
patients between January 1994 and December 1997, along with an 
audit of 214 medical records by Clinical Partners. Analysis included 
demographc characteristics; OUR; utilization and cost of inpatient, 
ambulatory, subspecialty care; and pharmacy. 
Results: Demographically, the population was: 51% Blacks, 36% 
Whites, 12% Hispanics. Entry CD4+ <200 was seen in 36% of 
Blacks, 44% of Whites, and 511% of Hispanics. Following the initia- 
tion of HAART therapy, Blacks had a 60% decrease in OIIR, Whites 
a 72% decrease and Hispanics a 24% increase. There was a 2% 
decrease in admissions among Blacks, a 19% decrease in Whites, but 
a 17% increase among Hispanics. Changes in per patient per month 
(PPPM) cost between 1996 and 1997 respectively were: $1357 and 
$1169 for Blacks; $1410 and $1 270 for Whites; and $1623 and $1697 
for Hispanics. Overall total cost between 1996 and 1997 decreased 
by 14% in Blacks, decreased by 10% in Whites, and increased by 1% 
in Hispanics. 
Conclusions: During this sudy, Hispanics constituted the largest 
population to enter late into medical care with a CD4+ <200. 
Increased OIIR, increased hospital admissions and higher PPPM cost 
were greater among Hispanics, in comparison to Blacks or Whtes. 
These findings suggest some variability in clinical/economic 
outcomes based on patient ethnicity. Further analysis is required to 
address demographic changes in the epidemic. 
AIDS-defining diseases in HIV-I-infected 
children from ‘Dr Victor Babes’ Hospital, 
Bucharest 
D. Duiculescu, E. Mihai, C. Patru, C. Oprea, R. Radoi, G. 
Scurtu, P. Calistru, E. Ceausu, L. Paun. ‘Dr Victor Babes’ Hospital of 
Infectious and 3opiCal Diseases, Bucharest, Romania 
Objectives: To define opportunistic infections in HIV-infected chil- 
dren. 
Methods: A total of 1083 hospitalized and outpatient HIV-1- 
infected children were clinically and immunologicly reclassified 
according to CDC 1994 categories between 1989 and 1998. 
Results: Of 1083 children with HIV-1 infection, 201 (18.5%) 
were classified with AIDS-defining conditions. The most common 
diseases were: recurrent bacterial infections 60.7%; HIV encephalo- 
pathy 25.4%; cryptosporidiosis 13.4%; lymphoid interstitial pneu- 
monia 12.4%; Pneumocystis carinii pneumonia 11.4%; extrapulmonary 
and disseminated tuberculosis 9.5%; esophageal candidosis 6%; cryp- 
tococcosis 4.5%; Kaposi sarcoma 2.5%; pulmonary candidosis 2.5%; 
lymphoma 2%; cytomegalovirus retinitiddisease 1.5%; isosporidiasis 
1%; cerebral toxoplasmosis 1%. 29 children (14.4%) were diagnosed 
with myoclonic encephalopathy of unknown etiology to date. Due 
to the high prevalence oftuberculosis, wasting syndrome is still under 
evaluation. 
Conclusions: In our patients, the most common diseases differ 
from those reported in western Europe. We have found a higher inci- 
dence of recurrent bacterial infections, tuberculosis and Kaposi 
sarcoma. 
Ip960) Of economic’clinical outcomes Of 
HIV management in a private managed care 
organization versus public clinic 
lp9621 The situation of HIV/AIDS infection in the M.K. Rawlings’, M. Pasley’, (3. de Guzman’, D. Lapins’. 
’Southeast Dallas Health Center, Parkland Health G Hospital Systems, 
Dallas, T X ,  ’Clinical Partners, Sun Francisco, CA, USA District of Constantza 
Objectives: To evaluate the differences in clinical and economic 
outcomes between the HI\‘ populations of private southwest Hospital Constantza, Constantza, Romania 
S. Rugina, C.S. Lungu, C.N. Rugina, S. Halichidis. City  Clinical 
managed care organizations (M) and a public clinic in Texas (p). 
Methods: Claims data on HIV-infected patients, seen between 
January 1996 and December 1997 in a Ryan White Title Ill setting 
and in private managed care plans, were analyzed regarding patient 
demographics, opportunistic infection incidence rate (OIIR), 
immune profile (IP), hospital and oral medication, and total cost by 
retrospective chart review. 
Results: HAART was initiated in October 1996 in the P setting, 
6 months after its availability in the M setting. There were compara- 
ble years of HIV experience among the providers in each setting. 
Objectives: To present the situation of HIV/AIDS infection in the 
district of Constantza up to 1 October 1998. 
Methods: A retrospective study of the HIV/AIDS statistics of the 
Department of Public Health in Constantza. 
Results: Up to 1 October 1998, 2375 cases of HIV/AIDS were 
considered. Ofthese, theer were 539 cases ofHIV infection and 1836 
cases ofAIDS. Ofthe cases of HIV infection, 371 ofthe patients were 
children and 168 adults, and of the cases of AIDS, 1267 were chil- 
dren and l 19 adults. Of  the total presented, the new cases considered 
in 1997 were: 220 cases of children with HIV infection, 12 cases of 
adults with HIV infection, 76 cases ofAIDS infection in children and 
16 cases of AIDS infection in adults. Of  the new cases considered 
during this year until 1 October, only two cases were reported of 
HIV infection in adults, 35 cases of children with AIDS and 29 of 
adults with AIDS. So far, 575 cases of child death and 31 cases of 
adult death have been reported. 
Conclusions: The morbidity of HIV/AIDS has not changed in 
spite of efforts at hygiene education carried out by the medical insti- 
tutions and by non-governmental organizations and the mass media 
from 1991 to the present. Compared with previous years, during the 
current year we have been able to observe a decrease in cases of 
HIV/AIDS infection in children and an increase of cases of infection 
in adults. 
Conclusions: Comparable results of suppression were seen in 
both a managed care setting and a Ryan White Title 111 program after 
initiation of H M T ,  in spite of PI therapy being available 6 months 
earlier in the private sector population. The study suggests compara- 
ble outcomes in both settings in spite o f  differences in patient demo- 
graphics. 
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I P963 I Risk factors for HIV transmission in Russia in 
1987-98 
N. Ladnaia, V. Pokroversuskiy, M. Bochkova, E. Buravtsova. 
Department oj Epidemioloa, Russia AIDS Center, Moscow, Russia 
Objectives: To study the risk factors for HIV transmission in differ- 
ent periods of epidemic HIV infection in Russia. 
Methods: The analysis of the information received in the Russian 
AlDS Center on the main risk factors for HIV infection on every 
patient registered in Russia. 
Results: 10 043 HIV-infected Russian citizens had been regis- 
tered in Russia on 1 November 1998 since 1987 when the first HIV 
case was registered in Russia. We divided the HIV epidemic in Russia 
into three periods. These time periods are characterized by a domi- 
nation of different risk factors for HIV infection and different speed 
of spread of the infection, as well as the regions of its distribution. A 
total of 442 HIV-positive Russian citizens were reported in the first 
period from 1987 to 1990, and of these, 57% were infected in hospi- 
tal settings. 272 cases were connected to the use of non-sterile 
medical instruments and equipment in several hospitals in southern 
Russia. During the second period from 1991 to 1995, 635 HIV 
infections were registered. 93% of people with known risk factors 
had been infected through sexual intercourse. The main risk factor 
for infection was homosexual contact (50% of people with known 
risk factor). A total of 8987 HIV-positive Russian citizens from 
almost all Russian regions were registered in the period from 1996 
to 1998. Drug use was recognized as the main risk factor for at least 
4667 registered cases (86.3% of all people with known risk factors 
registered in these 2 years). Heterosexual transmission occurred in 
279 cases. 
Conclusions: The first period, 1987-90, can be defined as a 
period of early introduction and slowly spreading transmission of 
HIV in Russia. During the second period from 1991 to 1995, the 
sexual transmission of HIV dominated and the speed of HIV spread 
remained slow. The period from 1996 to 1997 was characterized by 
the fast spread of HIV among intravenous drug users. 
lp9641 Opportunistic infections in Romanian HIV- 
infected patients 
S. Erscoiu, D. Duiculescu, E. Ceausu, S. Geaniai. Clinic OfInfeclious 
and Tropical Diseases, Bucharest, Romania 
Objectives: To present some characteristic aspects of opportunistic 
infections (01) in Romanian HIV-infected patients. 
Methods: A retrospective study detected 0 1  in 1676 patients 
(1083 children and 593 adults) hospitalized in our clinic between 
1985 and 1998. The cumulative (adults and children) percentage of 
0 1  was compared to the percentages of 0 1  in the USA, Europe and 
Africa. With regard to TB infections, we analyzed only TB menin- 
goencephalitis because of the high number of TB infections in 
Romania and the lack of exact data in other countries. 
Results: We diagnosed 33.9% cases ofAIDS in adults and 24.19% 
in children. Recurrent systemic infection was the most frequent 0 1 ,  
representing 11.45% compared to 2% in the USA and 11.2% in 
Europe. The second most common 0 1  was TB meningoencephali- 
tis-l1.23% cam compared to 0.55% in the USA and 5.3% in 
Europe. PCP, the most frequent 0 1  in the world, was very rare in 
Romanian patients-only 2.38%. 14.47% of patients died because of 
01. 
Conclusions: 0 1  are more frequent in adults compared to chil- 
dren. PCP infections due to cytomegalovirus and Cryptococcus neojor- 
mans infection are very rare in Romanian patients. Recurrent 
systemic infections and TB meningoencephalitis are the most 
frequent 01. Clinical manifestations associated with AIDS, such as 
herpes simplex and herpes zoster infections, are kequently present in 
Romanian HIV-infected patients. 
)p965) Systemic bacterial infections in HIV-infected 
patients 
S. Geamai, C. Cristea, E. Ceausu, S. Erscoiu, 0. Dorobat, D. 
Duiculescu, P. Calistru, L. Paun. Infectious and Tropical Diseases 
Clinic ‘Dr V Babes’, Bucharest, Romania 
Objectives: To study clinical and prognostic aspects, as well as the 
etiologic features, of systemic bacterial infections in HIV-infected 
patients. 
Methods: We studied 53 HIV-infected patients with systemic 
bacterial infections (bacteremia, sepsis) admitted to our clinic 
between January 1996 and December 1997. Automatically performed 
blood culture was the main diagnostic method, but we also used clin- 
ical data and biochemical investigations. 
Results: There were 32 children and 21 adults with mean ages of 
9.6 and 37.8 years respectively. There were 66 positive blood cultures, 
45 in children and 21 in adults. The etiologic spectrum was domi- 
nated by Streptococcus pneumoniae in children (15 cases); Gram-posi- 
tive and Gram-negarive bacteria were equally represented in adults, 
with a slight predominance of Staphylococcus group (5 cases with 
Staphylococcus epidermidis and one case with Staphylococcus aureus). The 
organisms’ site of entry was pulmonary in most patients, both chil- 
dren and adults. In almost half of the cases we could not establish the 
site of entry. We determined the CD4 cell counts in 19 adults and 
24 children, with mean values of 108.3/mm3 and 371.8/mm3 respec- 
tively. 19 adults were clinical category C and two clinical category B. 
Five adults and six children died. 
Conclusions: Gram-positive bacteria prevail in the etiology of 
bloodstream infections in HIV-infected patients. In a significant 
number of cases, we could not specify the organisms’ site of entry. 
Systemic bacterial infections have few clinical symptoms, but possi- 
ble severe evolution in HIV-infected patients, so rapid dagnosis and 
treatment are necessary. 
lp9661 Nosocomial transmission of TB in HIV patients 
A. Dominguez, J. Aznar, M.C. Garcia, M.A. Muniain, J.C. 
Paloniares. Facultad de Medicina, University oj Seville, Seville, Spain 
Objectives: (a) To correlate the clinical and radiologic patterns of 
tuberculosis (TB) with the RFLP analysis of M .  tuberculosis isolates 
from HIV-infected patients, and (b) to detect nosocomial transmis- 
sion of TB. 
Methods: Retrospective study of 44 HIV-infected patients admit- 
ted to the hospital diagnosed as having pulmonary tuberculosis 
during a 3-year period (1993-95). Two groups of patients were 
defined: group A, 18 patients with clinical and radiologic patterns 
suggestive of pulmonary TB reactivation, and group B, 26 patients 
with atypical radiologic patterns suggesting recent transmission. M .  
tuberculosis was isolated from all patients and susceptibility testing by 
a radiometric method was performed. IS6110 RFLP analysis were 
performed in 23 clinical isolates, 9 from group A and 14 from 
group B. 
Results: Two isoniazid-resistant strains and 1 MDR isolate were 
found in both groups of patients, while 1 rifampin-resistant isolate 
only was found in group A. No cluster in group A and only 1 clus- 
ter of two patients by RFLP analysis were found. However, 18 
A b s t r a c t s  345 
distinct RFLP patterns were obtained from the 23 strains isolated, 
and 5 banding patterns were shared by two patients (10 strains 
Conclusions: N o  correlation could be established between the 
clinical-radiologic pattern of TB and the molecular fingerprinting of 
the strains. Although most of the patients have been admitted several 
times to the hospital, nosocomial outbreak of TB was not detected, 
and uosocomial transmission of T B  can be excluded in spite of the 
5 clusters found in the HIV-infected patients. 
(43.5%)). 
lp9671 Comparison of genotypes of Mycobacterium 
avium isolates infecting HIV-negative and HIV- 
positive patients, in Greece 
P.T. Tassios. A. Kyriakopoulos. P Matsiota-Bernard, E. Marinis, L 
Zerva, N.J. Legakis. Medical Scliool, Uniuersity q f A f i i o i s ,  Athem, 
Green 
Objectives: To determine the genotypes and clonal relationships of 
M.  auirrm isolates infecting HIV-negative and HIV-positive patient\. 
Methods: Forty-one human clinical isolates have been identified 
as M. auium using PCK with the sets of species-specific primers 
AV6iAV7 and IN38iIN41. Thle isolates were from 23 AIDS patients 
with disseminated disease, and 18 HIV-negative patients: 11 children 
with cervical lymphadenopathy, and five adults with lung infection, 
one with intra-abdominal infection and one with hip-joint infection. 
Pulsed-field gel electrophoresis (PFGE) of genomic DNA was 
performed following digestion with the restriction endonuclease 
X6aI. The PFGE patterns were compared using the GelCompar 
computer software. 
Results: By visual comparison of PFGE patterns, 10 different 
PFGE types, differing by four or more DNA fragments, could be 
distinguished in the AIDS group, with 11 of 23 isolates clustering in 
a single type. Similarly, 10 PFGE types were observed in the HIV- 
negative group, with five of 18 isolates clustering together. When the 
PFGE types from both groups were compared using a computer soft- 
ware program, four clusters with similarity above 85% were observed, 
indicating that strains from both patient groups were genetically 
related. 
Conclusions: These resulits suggest that, though there exists 
genetic variability among M. mium isolates froin HIV-negative and 
HIV-positive patients, related strains seem to account for a large 
number of infections in both p u p s  in  Greece. 
lp9681 Pneumonia in patients with human 
immunodeficiencv virus infection 
N. Benito, A. Ra56, M. Luna, C. Agusti, J. Gonzalez, E Garcia, 
J.M. Mir6, T. Pumarola, A. Moreno, A. Torres. Seruires qf!fl@ctious 
Diseases, Mifrobiology and Ptzeuwrology, Clinic Hospital, Barcelona, Spairr 
Objectives: To study the incidence, etiology, evolution and prog- 
nostic factors of pneumonia in patients with HIV infection. 
Methods: In a prospective 5,tudy we monitored a cohort of 2240 
HIV patients for up 8 months during 1998. All patients with a radio- 
logic pulmonary infiltrate were included. In all cases CD4 lympho- 
cyte count, viral load, chest radliography, blood and sputum cultures, 
and serology for 'atypical' causes of pneumonia and Lqionella urinary 
antigen were performed. In patients with bilateral infiltrates, serum 
cytomegalovirus antigen and a bronchoalveolar lavage culture were 
also performed. All patients were followed until radiologic 
resolution. 
Results: 50 patients (19 fen-iale and 31 male) were included. The 
mean age was 36 years (SD 9.1, range 22-61), 34 patients (68%) were 
injection-drug users, 7 were homosexual men (1 4%) and 8 (16%) h d  
other HIV-associated risk factors. The median C114 lyinphocyte 
count was 97/nim" (SD 218, range 4-882) and the median viral 1o.d 
158 250 copiesiml (range: indetectable to 1 665 000 topic\). In 8 
patients (1  6%) the studied episode represented the HIV infection 
debut. 34 (68%) were not taking antiretrovird therapy. I n  30 a s e s  
(60%) an  etiologic diagnosis was achieved: P n e u m o q ~ i s  cauiriii i n  IS 
cases (27'%), Sfreptororomis pneuiiioniar in 6 (1 6%), .Myropfasiiio pi i?r{ -  
moriiae in 3, puhiionary emboli due to Sr~p/iy/ococnrs n i w i u  ni 3 ,  
AspeTillus spp. in 2, Haetnophilrrs irzjtteiizac in 1 and oat-cell carci- 
noma in 2. Five (10'%) patients died. In the multivariate maly\is, 
respiratory insufficiency (OK 9.5; p=0.043) and niechariical venti- 
lation (OR 14.3; p=0.044) were the only factor< associatcd with 
mortality 
I P969 I Risk factors associated with oropharyngeal 
colonization and infection by fluconazole- 
resistant Candida isolates in HIV-infected 
patients 
M. Mask F. Gutitrrez, V Ortiz de la Tabla, C. Martin, A. 
Sevillano, I. Hernindez, A. Martin-Hidalgo. Hospiral Uriivcuisrario 
de Elche, Elche, Spain 
Objectives: To investigate the factors that lead to oropharyripxl 
colonization and infection by fluconazole-resistant Cnridida irolates in 
patients infected with HIV 
Methods: Cross-sectional study in HIV-infected patient\. Carididu 
strains were classified according to current NCCLS reconiniriida- 
tionr. 
Results: 168 Carzdida strains were isolated from 153 patimts 
(88%1), 28 of them(lh%) with oropharyngeal candidiatic. Overall, 
12% (N=lO) of the patients had at least one resistant organism 
(MIC=64). Patients with resistant isolates had lower (:D4 cell counts 
(median, 72 versus 205 cells/mm') and they had been trexcd more 
frequently with fluconazole (adjusted odds ratio [OR] 3.4, conti- 
dence interval (CI) 1.1, 11.0, P=O.01). They also had more oftell 
opportunistic infections (OR 5.2, CI 1.5, 20.1, P=0.02) ,  oral 
caiididiasis (OR 5.5, C1 1.7, 16.9, P=O.OOl) and esophageal candidi- 
asis (OR 7, CI 1.7, 28.9, P=0.003), and had been treatcd niore 
frequently with antituberculous drugs (OK 6.03, CI 1 .X, 19.0, 
P=0.0003), ciprofloxacm (OK 6.0, CI 0.94, 36.66, P=O.O4), other 
antibiotics (OR 3.4, CI 1.1, 10.7, P=O.01) and stcroids (OK 4.03, 
CI 0.9,17.6, P=O.OZ). Multivariate analysis showed that  thc inde- 
pendent risk factors for fluconazole resistance were antibiotic treat- 
ment against the most frequent opportunistic infection\, mainly 
antituberculous drugs and ciprofloxacin (OR 5.54, CI 1.87, 10.44, 
P=0.002), and either oral candidiasis ( O K  4.22, (:I 1.39, 12.X1, 
P=O.Ol) o r  previous treatment with fluconazole (011 3.41, Cl l . l I ) ,  
Conclusions: Our  results indicate that previous use of,intitiiber- 
culous drugs and ciprofloxacin, and fluconazole cxpowre, were the 
strongest determinants for acquisition of resistant Candidn strains. 
10.60, P=0.03). 
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m1 Prospective evaluation of the molecular 
epidemiology of S. aureus (SA) colonization in 
HIV infection 
E Perdreau-Remington', J.N. Martin', H.E Chainbers', J.L. 
Gerberding, B.L. Lee', M.G. Tacube?. 'Department $Medicine, 
University .J' Cal$rnia, Sun Francisco, U S A ;  'Uniuersity .J' Bern, Bern, 
SwitIrriand 
Objectives: To determine the prevalence of SA nasal colonization 
in HIV-infected patients (IV and non-IV drug users (IVDU)) and the 
clonality of the isolates of patients persistently colonized. 
Methods: SA cultures were performed on consecutive HIV- 
infected volunteers recruited from San Francisco General Hospital's 
clinics. Those who were positive initially and upon culture 7 days 
later were considered persisters. Antimicrobial susceptibility and 
PFGE of restriction fragments (Smal) were determined. Question- 
naires were used to obtain participants' demographic and clinical 
information. 
Results: Of 265 HIV-infected subjects, 72 (27%) were IV drug 
users (IVDU), and 113 (42%) had an initial positive SA nasal culture 
(33/72 (45%) in IVDU; 80/193 (41%) in non-IVDU). Of the 113 
initially SA-positive subjects, 91 returned for a repeat culture, of 
whom 76 had a second consecutive culture. 20 (28%) IVDU and 56 
(29%) non-1VDU were considered persisters. Of these 76, 17 (22%) 
were colonized with clone A, 8 (11%) with clone B, 5 (6%) with 
clone C, 5 (6%) with clone D, 4 with clone E and 2 each with clones 
E G, I and J, and 29 (38%) were colonized with unique clones. 
Except for clones A and D, which were each identified in 2 IVDUs, 
the 16 other IVDUs had unique clones. Seventy of 76 (92%) isolates 
were penicillin resistant, but only 3 (4%) were methicillin resistant. 
Resistance to TMS was 40%. erythromycin 35%, clindamycin 6%, 
rifampin 3% and mupirocin 1%. 
Conclusions: Nasal colonization with SA in HIV is high but is 
not associated with IVDU. Over one-half of persistently colonized 
HIV-infected patients share clones found in other patients (clones 
A-E) . 
(p9711 Nosocomial central venous catheter-related 
sepsis in HIV-I-positive patients 
M.F. Bianco Chinto, R. Fora, D. Sciullo, R. Ruffatto, E. Nigra, 
M.L. Soranzo. Ward B, Infectious Diseases, Amedeo di Sauoia Hospital, 
Turin, Italy 
Objectives: To assess risk factors associated with the development 
of nosocomial central venous catheter-related sepsis (NCVC-RS) in 
HIV-l+ patients. 
Methods: From June 1991 to June 1998 we studied 190 CVC- 
inserted hospitalized HIV-l+ patients: 135 males, 55 females, median 
age 36 years (range: 23-68 years); 136 IVDUs, 31 homosexuals, 19 
heterosexuals and 4 others. For each patient a medical doctor and 
an epidemiologist completed a record with sociodemographic, 
immunologic and virologic data, previous and current therapy, inva- 
sive procedures, and clinical and microbiological data. Univariate 
statistics were performed using chi-square and non-parametric tests, 
and multivariate analysis using logistic regression. 
Results and conclusions: The median hospitalization time was 
18 days (range: 3-186). CVC-RS occurred in 13 patients (6 males, 
7 females) in a median time of 16.5 days (range: 9-129) after CVC 
setting. The incidence rate of sepsis was 6.8 per 100 CVC-inserted 
patients and 0.24 per 100 catheter-days. On univariate analysis 
NCVC-RS was associated with female sex @=0.04; R R  2.9/CI: 
1.01-8.1), previous surgery (p=0.008; RR: 7.2/CI: 1.65-21.1), 
cutaneous colonization with multidrug-resistant S. aureus or S. epider- 
midis @=0.0002; R R :  7.6/CI: 2.2-26.6), any infective focus 
(p=0.0005; RR: 8.5/CI: 2.7-26.3). time of catheter use 21 days 
(p=0.048; RR: 2.8/CI: 0.98-7.8 borderline) and time of hospital- 
ization (mean values 61.2 versus 23.3 days, p=0.019). Multivariate 
analysis confirmed the independent association of NCVC-RS with 
cutaneous colonization ( O R  2.11) and previous surgery (OR: 2.14), 
p=0.002. Sxpidermidis MR, S. aureus, E. roli and Candida spp. were 
the commonest microorganisms isolated . No relationships emerged 
between immunologic and virologic status and NCVC-RS occur- 
rence. 
m1 Evaluation of a new CMV plasma quantitative 
test in AIDS patients: COBAS AMPLICOR CMV 
MONITOR compared with pp65 Ag and 
AMPLICOR CMV 
I. Pellegrin, C. Binquet, I. Garrigue, G. Chene, H.J.A. Fleury, J.-L. 
Pellegrin. C H U  Pellegrin, Bordeaux, France 
To compare the results of CMV (pp65Ag), AMPLICOR CMV 
(CMVQual, Roche) and the new quantitative COBAS 
AMPLICOR CMV MONITOR (CMM, Roche) assay for CMV 
infection in AIDS patients. Between November 1995 and September 
1997, 80 AIDS patients (<lo0 CD4+ cells/mL) were enrolled and 
followed every 2 months with blood sample collection for pp65Ag, 
CMVQual and CMM; 23 patients met criteria for CMV disease 
diagnosis (CDD); 407 samples were evaluated by pp65Ag, CMVQual 
and CMM. pp45Ag CMVQuaF CMVQual- CMM' CMM- n +(0 
+cell) 53% 46.6% 54.3% 45.7% 105 +(5 +cells) 84.7% 15% 84.7% 
15.2% 59 -(<l+cell) 2.6% 97.3% 2% 98% 302 -(<5+cells) 4% 
96% 3.7% 96.3% 348 The discordant results @p65Ag+0 +cell)/ 
CMVQual- or CMM-) showed low pp65Ag (median=3 and 2.5 
'cells). The CMV load in @p65Ag-(<l+cell) /CMM+) discordant 
results was between 663 and 16 500 copies/mL. The quantitative 
results of pp65Ag and CMM were correlated (r=0.75). CMM assay 
is sensitive and more specific than pp65 Ag for detecting a CMV 
infection. This assay is rapid, is quantitative and does not depend on 
the rapid processing of samples. It can be easily used for CDD and 
monitoring antiviral therapy 
)p9731 Viral loads in children dually infected with HIV- 
1 and cytomegalovirus (CMV) 
Y.S. Boriskin', M. Sharlandz, J.C. Booth'. 'Department OfMedical 
Microbiolou, 'Paediatric A I D S  Unit, St Geove's Hospital Medical 
School, London, UK 
Objectives: A cross-sectional study to exanline the relationship 
between viral loads for CMV and HIV in a cohort of children with 
vertically acquired HIV infection. 
Methods: Semiquantitative nested PCR was used to compara- 
tively measure HIV-1 proviral DNA and CMV genomic DNA in 
peripheral blood leukocytes of56 children in relation to age and clin- 
ical staging of HIV disease. 
Results: The CMV load was highest in G2-year-old HIV-posi- 
tive children with rapidly progressing disease (range 1-7143 copies/ 
100 ng DNA median 125) and was significantly lower in 3-13-year- 
old children @=0.0028). HIV-1 viral load, though higher in young 
children, did not show the same marked reduction with age seen in 
CMV Over a 1-year period, testing of samples for both viruses 
revealed a discordant relationship between viral load for CMV and 
HIV-1. 
Conclusions: CMV viral load falls faster than HIV viral load in 
children. The level of CMV replication was independent of that of 
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HIV, suggesting that any combined effect on disease progression was 
cumulative rather than additive. 
lp974] Reactivation of hepatitis B virus (HBV) in HIV 
patients 
S .  Cercenado, M. l>el Alanio, .4. Perez, M. Calvo, M.D. Martin, 
A. Delgado-Iribarren. Swero Cklioa Hospital, Madrid, S+airr 
Background: Reactivation of HBV virus is a well-known clinical 
entity in HBsAg+ patients, although it is not frequent in HIV infec- 
tion. Exceptionally, cases have been described in HBsAg- patients. 
We describe four cases ofhepatitis B virus (HBV) reactivation in HIV 
patients, with special emphasis on two of them who were previously 
HbsAg negative. 
Patients: Two patients were HBV chronic carriers w t h  no DNA 
HBV detectable in serum and the other two had markers of past 
infection (HUcAb alone, including HBeAb and DNA HBV nega- 
tive). Acute hepatitis was last documented in one patient 4 years 
before reactivation. All of them were male, HIV positive and anti- 
HCV negative, except for one patient. 
Methods: Serologic markers by EIA (HBV and HIV by ES-700, 
Boehringer Mannheim, HDV Sorin, HCV Abbott), and DNA HBV 
by commercial hybridization (Digene, Murex). 
Results: In all cases, DNA VHB (355, 372, 426 and 54 pg/mL 
respectively) and HBeAg appeared in the context of acute hepatitis 
or transaniinase elevation, with appearance of HBsAg in the two 
patients previously negative and a weak or non-HBcAb IgM 
response. All developed chronic hepatitis, with persisting HBeAg, 
HBsAg and DNA VHB positivity All but patient 3 died (oppor- 
tunistic infections and lymphoma). 
Conclusions: Although there are few case reports of HBV reac- 
tivation in HIV patients, it is a clinically feasible event, so it has to be 
included in the differential diagnosis of acute hepatitis or transaniinase 
elevation. Of particular interest are the HbsAg-negative and HbcAb- 
positive patients in whom the diagnosis may not be suspected, and 
who may be potential silent carriers. 
m1 Antibodies to Bartonella henselae in HIV 
patients 
J.R. Blanco, J.A. Oteo, V Martinez de Artola, E. Ramalle, V 
Ibarra, E. Ptrez. Hospital de La Rioja, Lofro'io, Spain 
Objectives: To deterinine the seroprevdence of antibodies to 
Bartonella hctisrhe ainong HIV patients. 
Methods: During October 1998, HIV patients and healthy blood 
donors (control) were asked to complete a questionnaire (age, sex, 
tobacco intake and daily alcohol consumption) and their seruni 
samples were analyzed (IgG antibodies to B. kenselac by IFI) (MRL 
Diagnostics). In HIV Patients, we also analyzed cat ownership, intra- 
venous drug use, CD4 lyniphocyte counts, AIDS-associated diagno- 
sis, anti-HIV drug use and Ptieurnocystis carinii prophylaxis. Criteria 
for exclusion were infections during the 2 months before the study, 
previous diagnosis of cat scratch disease and other infections due to 
Bartoriclla spp, An IFA titer of 1 :h4 was considered positive. 
Results: Nine (17.3%) of S 2  HIV patients had antibodies to B. 
herrselae, although only five (5.88%) of 85 blood donors had 
detectable titers (OR 1.70; 95% CI 0.34-8.54). When we analyzed 
the paraineters of both groups, we did not find any difference. 
although daily alcohol consumption had a high risk but not signifi- 
cant (OK 6.05: 95% CI 0.70-52.23). In HIV patients, we could not 
find any significant difference, but we found the following outcoines: 
daily alcohol consumption (OR 5.28: 95% CI 0.59-47.39), sex male 
(OK 3.21: 95% CI 0.34-30.51) and cat ownership (OK 2.44; 95'% 
Conclusions: A significant titer of antibodies to B. lieriselnr was 
found in 17.3'% of HIV patients, although this was not significant in 
relation to blood donors. None ofthe parameters analyzed were asso- 
ciated with seropositivity to B. hensdae. (Supported by a grant from 
the Gobierno de La Kioja, Spain.) 
CI 0.3-19.39). 
)p976) Paracoccidioidomycosis associated with 
acquired immunodeficiency syndrome (AIDS) 
S. No&, F.H. Aoki, M.H.S.L. Blotta, M.L. Branchini, P.M.0. 
Papaiordanou. Rio dejaneiro, Brazil 
Objectives: To deterniine the prevalence of human inmiunodefi- 
ciency virus infection (HIV) among patients with paracoccid- 
ioidoniycosis and to compare the clinical finding\ and epidemiologic 
aspects of paracoccidioidoniycosis in AIDS and in non-AIDS 
patients. 
Methods: Consecutive patients with paracoccidioidoinycosis 
were followed between 1995 and 1998 and HIV tests were 
performed. The clinical charts of all patients with paracoccid- 
ioidomycosis between 1987 and 1998 were also reviewed and HIV- 
positive patients (cases) were compared to H1V-negative patients 
(controls). 
Results: In the 4-year period, 129 patients had serologic tests for 
HIV performed; 3 were positive (prevalence of 2.3%). Eleven HIV- 
positive patients were compared to 126 HIV-negative patients. There 
were no differences regarding gender, age, clinical form (acute or 
chronic), duration of clinical manifestations before diagnosic and 
symptoins or signs (cough, fever, malaise, weight lots, adenopathy). 
In patients with the acute form, the baseline serum antibody titer was 
more frequently negative in AIDS patients (p=0.02). The median 
bateline serum antibody titer was higher in AIDS patients than in 
non-AIDS patients, in both chronic and acute fornis (p=O.OI and 
p=0.007, respectively). Mucocutaneous involvement was niore 
frequent in AIDS patients @=0.02). 
Conclusions: The prevalence of HIV infection in patients with 
paracoccidioidomycosis was similar to that in the general population, 
suggesting that there is no association between paracoccidioidoiiiy- 
cotis and AIDS. Although the clinical presentation of paracoccid- 
ioidoniycosis in AIDS patientt was similar to that in non-AIDS 
patients, mucocutaneous involvenient and baseline serology seems to 
be differeut. These data niuct be taken into account when evaluating 
patients in endemic areas for paracoccidioidomycosis. 
Clostridium difficileassociated diarrhea 
(CDAD) in HIV-infected patients: risk factors 
and recurrences 
J.M. Garcia-Lechuz, L. Alcali, I! Miralltls, C. Garcia-Rey, 8. 
Padilla, T. Peliez, E. Bouza. Seruicio dc A4icrobiologia y Et!fcuniedades 
lr~fercios, Hospital General Universitauio, Modrid, Spain 
Although uncoinnionly reported, Closlridium d!ffitik is, in our expe- 
rience, a very important cause of diarrhea in hospitalized HIV- 
infected patients. 
Objectives: To elucidate distinctive features concerning HJV 
patieiitc with CDAD (CIIAl)+) and with non-CDAl> (CDAD), and 
risk factors for rrcnrrences. 
Methods: We prospectively reviewed 174 HIV patients with dinr- 
rhea admitted at our institution froin January 1993 to January 1998. 
One hundred and twelve patients (61.3'%) were CIIAI>+ (215 
episodes, an incidence of 21 episodes/lOOO admissions), and 62 were 
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not. Recurrent CDAD (CDAD+R+) occurred in 30 (26.7%) of the 
112 CDAD+ patients. We compared cases with diarrhea associated 
or not with C. d@cile (CDAD+/CDAD-) and also risk factors for 
recurrent episodes (CDAD+R+/CDAD+R-). 
Summary: Risk factors associated with CDAD positivity were (p 
< 0.05): mean hospital stay (46 versus 19 days); number of oppor- 
tunistic infections (2.5 versus 3.6); previous antibacterial (60.7% 
versus 45.2%), antituberculous (57.1% versus 21%), anti-MAC 
(22.3% versus 9.7%), and antiviral (25.9% versus 4.8%) treatment. 
The only significant risk factor associated with recurrence was 
median hospital stay (42 versus 26 days). The crude mortality was 
similar for both groups but CDAD-related mortality was 24.1% in 
CDAD+R+ versus 6.1% in CDAD+R- (p < 0.05). 
Conclusions: Clostridium dficile should be searched for as a 
common cause of diarrhea in HIV-infected patients. Higher mortal- 
ity was associated with recurrent disease. 
1- Non-Hodgkin's lymphoma in an HIV-2-infected 
patient 
D. Serra, G. Carmo, M.L. Arahjo, M.J. Gomes. Seruico de Doencas 
Infecriosas, Hospital de Santa Maria, Lisbon, Portugal 
Non-Hodghn's lymphoma (NHL) is a well-known complication in 
persons with HIV-1 infection. In contrast, in HIV-2-infected indi- 
viduals, NHL is an extremely rare situation, with few cases reported 
in the world. 
The AA report a case of a 40-year-old man, black, heterosexual, 
and born and living in Guinea-Bissau, admitted to the Department 
of Infectious Diseases of Hospital de Santa Maria, in Lisbon, with a 
prolonged febrile syndrome and enlarged lymph nodes. The HIV-2 
serology came up positive and NHL was diagnosed by histologic 
examination of a cervical lymph node, and confirmed by bone 
biopsy. Chemotherapy led to complete remission, and the patient 
returned to his home country. Eight months later, he was referred to 
our hospital because of fever, eosinophilia and cutaneous lesions. A 
relapse was excluded in the course of intensive investigation (CT 
scan, bone biopsy, myelogram and hepatic biopsy), suggesting a larva 
migrans syndrome, based on epidemiology and a positive serologic 
test. Treatment with albendazole led to clinical remission and he was 
discharged again, but remained in Portugal. 
Two months later, he was re-admitted with fever, jaundice and 
prostration. Once again, NHL was rejected by preliminary investiga- 
tion. Because of deterioration of his clinical state with extreme levels 
of hyperbilirubinemia (800 mmol/L), pancytopenia and acute renal 
failure, a transjugular hepatic biopsy was done, revealing NHL 
relapse. Unfortunately, the patient died during the second day of 
chemotherapy. 
The AA consider the description of this rare clinical situation 
useful, considering the fact that the final diagnosis of NHL relapse 
was only possible in the final stage by a transjugular hepatic biopsy. 
1-1 AIDS-associated EBV-positive gastrointestinal 
high-grade B-cell MALT lymphoma: a case 
report 
A. Mastroianni', C. Canceheri', A. Sabbatid, M. Portolani', S. 
Pignatari'. 'Division of lnfctious Diseases, 'G.B. Morgagni' General 
Hospital, Forli, 'Laboratory of Virology, University o f  Modena, Modena, 
Italy 
Objectives: To report the detection of Epstein-Barr virus (EBV) 
genomic sequences in gastrointestinal sections from gastrointestinal 
high-grade B-cell MALT lymphoma in a patient with AIDS. 
Case report: A 54-year-old homosexual man with no past clin- 
ically obvious disease presented with a 1-month hstory of a viola- 
ceous, 3-cm plaque lesion on the left arm. HIV serology was found 
to be positive, CD4 cell count was 271 and HIV RNA was 617.187 
copies/mL. EBV serology was positive for IgG. Pathologic examina- 
tion of biopsy specimen of the skin lesion, including histology and 
immunohistochemical staining, revealed KS. ACT scan of the 
abdomen disclosed a marked mural thickening of the stomach, 
duodenum, cecum, ileum, and ascending and transverse colon. 
Histologic examination of biopsy specimens of the stomach, ascend- 
ing colon and cecum revealed high-grade NHL of the MALT type. 
Each formalin-fixed, paraffin-embedded tissue specimen of skin, 
gastric and intestinal lesions was tested by nested PCRS using specific 
primers to amplify EBV and HHV-8 DNA sequences. HHV-8 DNA 
was detected in KS cutaneous samples but not in NHL specimens, 
whereas both skin and NHL specimens proved positive for EBV 
DNA. 
Conclusions: In recent years, the identification of DNA 
sequences of EBV in cases of HIV-related NHL have suggested the 
possibility that these neoplasms might be associated with a viral etiol- 
ogy. Previous studies have linked EBV to a variety of tumors, includ- 
ing a high percentage of cases of nasopharyngeal carcinoma, Burkitt's 
lymphoma, Hodgkin's disease, post-transplant B-cell lymphoma, and 
also recently T-cell lymphomas, thymic lymphoepithelioma, salivary 
gland carcinoma, and urogenital carcinoma. To date, t h s  is the first 
reported case of visceral AIDS-related MALT lymphoma in which 
the EBV genome has been demonstrated in the tumor by PCR. 
Pediatric infections including vaccination II 
lpsso] Increased host defense of patients with cystic 
fibrosis (CF) after incubation with f! aeruginosa 
from their tracheal secretions 
D. Kunz, V. Sollich, C. Freytag, U. Schmidt, W. Konig. Imtitute of 
Medical Microbiology, Otto uon Gueriche University, Magdeburg, Germany 
Introduction: I? aemginosa is an important pulmonary pathogen in 
patients with CF, but the means by which it evades host defenses is 
still understood poorly. 
Methods: From 15 patients (age 6-24 years) with CF, the respi- 
ratory burst activities of PMN in whole blood after incubation with 
I? uewginosa isolated from these patients were compared with those 
from healthy donors. Additionally, the release of PMN elastase after 
incubation of isolated PMN with I? aeruginosa was measured. In these 
assays the bacterial killing was analyzed hy counting of CFUs 
Transmission electron microscopy was used to provide evidence of 
phagocytosis of mucoid and non- mucoid P uem@osa. 
Results: The respiratory burst activity of the PMN from the CF 
patients (with non-opsonized l? aeuginosa: 86-C7%; autologous 
